deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03483194

Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH) (REVEH)

Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care

Sponsor: L'effet Papillon

Conditions Hematologic Neoplasms
Interventions Kalinox Virtual Reality
Updated 7 times since 2018 Last updated: Jun 22, 2020 Started: Sep 6, 2018 Primary completion: Apr 20, 2020 Completion: Jun 19, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03483194, this PHASE2/PHASE3 trial focuses on Hematologic Neoplasms and remains completed. Sponsored by L'effet Papillon, it has been updated 7 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshotNot Yet Recruiting~Aug 2019 – ~Jul 2020 · 11 months · monthly snapshotRecruiting~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  4. Jul 2020 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

    Status: Recruiting → Completed

  5. Aug 2019 — Jul 2020 [monthly]

    Recruiting PHASE2_PHASE3

    Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

  1. Jun 2018 — Aug 2019 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

  2. Apr 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE2_PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • L'effet Papillon
  • Weprom
Data source: Weprom

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations